πŸ‡ΊπŸ‡Έ FDA
Patent

US 11576871

Formulations of cysteamine and cystamine

granted A61KA61K31/145A61K9/2054

Quick answer

US patent 11576871 (Formulations of cysteamine and cystamine) held by The Regents of the University of California expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/145, A61K9/2054, A61K9/282, A61K9/2846